Adragos Hub

Semisolid manufacturing covers topical and transdermal dosage forms that sit between liquids and solids in consistency. These products include creams, ointments, gels and pastes, and they must be manufactured with tight control over uniformity, stability, spreadability and product performance. At […]

A Guide to Pharmaceutical Product Testing Analytical testing is a critical function for any company involved in pharmaceutical manufacturing. The analytical department truly sits at the heart of what we do, bringing together science, quality, and compliance to make sure […]

The pharmaceutical industry continues to evolve, and sterile manufacturing is evolving with it. Shifts in patient needs, product complexity, delivery systems and production technology are changing how sterile products are developed, filled, packaged and released. For pharmaceutical companies, this means […]

Patients rely on pharmaceutical manufacturers to ensure that the medicines they are given are safe. For injectable products, aseptic filling is key, and facilities such as Adragos Jura must follow regulatory guidelines extremely carefully.  The product must be totally protected […]

Recently, Konstantinos Apostolou, R&D senior manager at our Athens Development facility, was featured in European Pharmaceutical Manufacturer, where he explored the rapid rise of highly potent active pharmaceutical ingredients (HPAPIs). The market is valued at $185.5 billion in 2024 and […]

Annex 1 to EU GMP for sterile products came into effect in 2023, and while technically it is for the EU, in practice it has rapidly become a worldwide standard. It has brought in a number of additional formal requirements […]